Management Team

As a trans-divisional initiative of the National Cancer Institute, the IMAT program’s management team comprises representatives from all extramural divisions of the National Cancer Institute as well as members of the Office of the Director and the Center to Reduce Cancer Health Disparities (CRCHD).  The trans-divisional, interdisciplinary nature of the management team is a unique feature and strength of the IMAT Program and promotes a more consolidated yet balanced representation of technology interests and needs across the NCI.

Office of the NCI Director

Dr. Tony Dickherber, Program Director
Phone: (301) 547-9980

Division of Cancer Biology

Dr. J. Randy Knowlton (
Dr. Nastaran Zahir (

Division of Cancer Treatment and Diagnosis

Pathology Investigation & Resources

Dr. Rodrigo Chuaqui (

Diagnostic Biomarkers & Technology

Dr. Tawnya McKee (
Dr. Miguel Ossandon (
Dr. Brian Sorg (

Biorepositories & Biospecimen Research

Dr. Ping Guan (
Dr. Lokesh Agrawal (

Division of Cancer Prevention

Dr. Guillermo Marquez (
Dr. Karl Krueger (

Division of Cancer Control and Population Sciences

Dr. Danielle Carrick (

NCI Technology Research Advocacy Partnership (NTRAP) Team

NTRAP explores opportunities for incorporating the patient’s perspective into management of the IMAT program and identifies opportunities offering the best chance for improving outcomes for these investments. Members of the NTRAP team include

Ms. Brittany Avin McKelvey, Patient Advocate and Graduate Research Scientist at Johns Hopkins University
Mr. Chuck Schmaderer, Patient Research Advocate
Ms. Deneen Hesser, Patient Research Advocate
Ms. Laurie Cynkin, NCI Office of Advocacy Relations